SM
VNDA icon

Sabby Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Sabby Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-113,165
Closed -$1.05M – 361
2015
Q1 		$1.05M Buy
+113,165
New +$1.28M 0.04% 186
2014
Q4 		– Sell
-81,600
Closed -$966K – 281
2014
Q3 		$847 Sell
81,600
-48,400
-37% -$634K 0.03% 161
2014
Q2 		$2.1M Buy
+130,000
New +$1.73M 0.09% 101
2014
Q1 		– Sell
-146,350
Closed -$1.82M – 275
2013
Q4 		$1.82M Buy
+146,350
New +$1.47M 0.12% 89
2013
Q3 		– Sell
-56,843
Closed -$607K – 223
2013
Q2 		$459K Buy
+56,843
New +$383K 0.03% 146

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sabby Management's VNDA Position: Q2 2015 in Review

Sabby Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2015, closing a stake of 113,165 shares — an estimated $1.05M sold.

Sabby Management first reported a position in VNDA in Q2 2013 and held it in 5 quarters. The position peaked at $2.1M in Q2 2014. 109 funds tracked by Wall St. Rank hold VNDA as of Q2 2015.

  • Sabby Management reported no remaining Vanda Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Sabby Management sold 113,165 Vanda Pharmaceuticals shares in Q2 2015, an estimated $1.05M.
  • Sabby Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Sabby Management's Vanda Pharmaceuticals position peaked at $2.1M in Q2 2014.
  • 109 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2015.

Based on Sabby Management's 13F filing for Q2 2015, filed 14 Aug 2015.